Chemomab Therapeutics (CMMB) Form 3 Anchiano Therapeutics / LAWRENCE HOWARD ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

HOWARD LAWRENCE

(Last) (First) (Middle)

C/O ANCHIANO THERAPEUTICS LTD.

5 KIRYAT HAMADA ST., P.O. BOX 45032

(Street)

JERUSALEM L3 9777401

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2020

3. Issuer Name and Ticker or Trading Symbol
Anchiano Therapeutics Ltd. [ ANCN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
American Depository Shares(1)	15,385	I	By Patata Beroa, LLC(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee stock options	(3)	07/02/2029	Ordinary Shares	55,000	1.03	D

Explanation of Responses:

1. Each American Depositary Share represents five ordinary shares, no par value per share, of the Issuer; the American Depositary Shares may be represented by American Depositary Receipts.

2. These securities are held directly by Patata Beroa, LLC. The Reporting Person's indirect ownership of 15,385 American Depositary Shares is based on the Reporting Person's percentage ownership in Patata Beroa, LLC, which holds 92,309 total American Depositary Shares of the Issuer.

3. 1/3 of the options vest one year following the vesting commencement date of July 3, 2019, and 1/12 at the end of each calendar quarter thereafter, until fully vested.

	/s/ Lawrence Howard	01/02/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.